Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
NCT ID:
NCT02493751
Group ID:
EG000
Title:
Axitinib + Avelumab With Lead-in
Description:
Participants received 5 mg axitinib tablets orally twice daily for 7 days in lead-in period (7 days) followed by 10 milligram/ kilogram (mg/kg) avelumab intravenously every 2 weeks along with 5 mg axitinib tablets orally twice daily, on Day 1 of each treatment cycle (duration of each cycle=14 days) in treatment period (up to maximum of 255.4 weeks).
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
16
Other Number Affected:
16
Other Number At Risk:
16
Study:
NCT02493751
Results Section:
NCT02493751
Adverse Events Module:
NCT02493751